These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17222281)

  • 1. Methadone in pregnancy: treatment retention and neonatal outcomes.
    Burns L; Mattick RP; Lim K; Wallace C
    Addiction; 2007 Feb; 102(2):264-70. PubMed ID: 17222281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of record linkage to examine illicit drug use in pregnancy.
    Burns L; Mattick RP; Cooke M
    Addiction; 2006 Jun; 101(6):873-82. PubMed ID: 16696631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of record linkage to examine alcohol use in pregnancy.
    Burns L; Mattick RP; Cooke M
    Alcohol Clin Exp Res; 2006 Apr; 30(4):642-8. PubMed ID: 16573582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J; Heilig M; Sarman I
    Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance agonist treatments for opiate-dependent pregnant women.
    Minozzi S; Amato L; Bellisario C; Ferri M; Davoli M
    Cochrane Database Syst Rev; 2013 Dec; (12):CD006318. PubMed ID: 24366859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy.
    Johnson S; Martin PR
    Am J Drug Alcohol Abuse; 2018; 44(3):310-316. PubMed ID: 28829626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infant mortality among women on a methadone program during pregnancy.
    Burns L; Conroy E; Mattick RP
    Drug Alcohol Rev; 2010 Sep; 29(5):551-6. PubMed ID: 20887580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of methadone maintenance treatment during pregnancy and pregnancy outcome parameters in women with opiate addiction.
    Peles E; Schreiber S; Bloch M; Dollberg S; Adelson M
    J Addict Med; 2012 Mar; 6(1):18-23. PubMed ID: 21817914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance agonist treatments for opiate dependent pregnant women.
    Minozzi S; Amato L; Vecchi S; Davoli M
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006318. PubMed ID: 18425946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using population data to examine the prevalence and correlates of neonatal abstinence syndrome.
    Burns L; Mattick RP
    Drug Alcohol Rev; 2007 Sep; 26(5):487-92. PubMed ID: 17701511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of timing of methadone initiation on perinatal outcomes following delivery among pregnant women on methadone maintenance therapy in Ontario.
    Guan Q; Sproule BA; Vigod SN; Cadarette SM; Greaves S; Martins D; Gomes T
    Addiction; 2019 Feb; 114(2):268-277. PubMed ID: 30276907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of neonatal outcomes amongst a methadone- and/or heroin-dependent population referred to a multidisciplinary Perinatal and Family Drug Health Service.
    Buckley V; Razaghi A; Haber P
    Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):464-70. PubMed ID: 23550533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy.
    Schindler SD; Eder H; Ortner R; Rohrmeister K; Langer M; Fischer G
    Addiction; 2003 Jan; 98(1):103-10. PubMed ID: 12492761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a substance abuse program for opioid-dependent nonurban pregnant women improves outcome.
    Meyer M; Benvenuto A; Howard D; Johnston A; Plante D; Metayer J; Mandell T
    J Addict Med; 2012 Jun; 6(2):124-30. PubMed ID: 22517450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of opioid dependence in pregnant women.
    Fischer G
    Addiction; 2000 Aug; 95(8):1141-4. PubMed ID: 11092062
    [No Abstract]   [Full Text] [Related]  

  • 16. Methadone and perinatal outcomes: a retrospective cohort study.
    Cleary BJ; Donnelly JM; Strawbridge JD; Gallagher PJ; Fahey T; White MJ; Murphy DJ
    Am J Obstet Gynecol; 2011 Feb; 204(2):139.e1-9. PubMed ID: 21145035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methadone treatment during pregnancy and its effect on the child. Better than continuing drug abuse, should be monitored by a specialized antenatal care center].
    Sarman I
    Lakartidningen; 2000 May; 97(18):2182-4, 2187-8, 2190. PubMed ID: 10850047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone maintenance program in a Swiss perinatal center: (I): Management and outcome of 89 pregnancies.
    Kashiwagi M; Arlettaz R; Lauper U; Zimmermann R; Hebisch G
    Acta Obstet Gynecol Scand; 2005 Feb; 84(2):140-4. PubMed ID: 15683373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of neonates conceived on methadone maintenance therapy.
    McCarthy JJ; Leamon MH; Stenson G; Biles LA
    J Subst Abuse Treat; 2008 Sep; 35(2):202-6. PubMed ID: 18077124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a canadian multisite cohort study.
    Ordean A; Kahan M; Graves L; Abrahams R; Kim T
    J Obstet Gynaecol Can; 2015 Mar; 37(3):252-257. PubMed ID: 26001872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.